Ian Explains
Ian Explains: Will biotech breakthroughs lead to super humans?

Ian Explains: Will biotech breakthroughs lead to super humans?

Medical technology could lead to a new breed of super humans.
On Ian Explains, Ian Bremmer looks at the evolution of human enhancement, tracing its roots from ancient history to recent ground-breaking tools like CRISPR gene editing, AI-powered prosthetics, and brain implants. These advances hint at a future of disease eradication, independence from physical disability, and recovery from traumatic brain injury. In a few short years, they’ve radically expanded the possibilities of how technology can improve the human experience and extend our lives.
But while biotechnology has incredible, transformative potential, it also brings lots of risks. Gene editing raises the specter of designer babies, eugenics, and even the potential for militaries to create superhuman soldiers. There’s also the question of privacy and data collection, as private companies like Elon Musk’s Neuralink gain further access to our medical histories. Ultimately, we need to strike a balance between embracing biotechnology’s life-changing potential while safeguarding our values, ethics and the very idea of what it means to be human.
US President Donald Trump listens to a question from a reporter prior to signing an executive order on AI next to Sriram Krishnan, Senior White House Policy Advisor on Artificial Intelligence, US Sen. Ted Cruz (R-TX), US Commerce Secretary Howard Lutnick, and David Sacks, chair of the President's Council of Advisors on Science and Technology, in the Oval Office at the White House in Washington, D.C., USA, on December 11, 2025.
Artificial intelligence and Donald Trump's foreign policy are creating huge tail risks for markets.
Last week, Microsoft released a new report offering an in-depth look at AI adoption across the United States, with state- and county-level insights for the first time. While more than 30 percent of working-age Americans now use AI tools, adoption remains uneven across regions, with significantly higher usage in urban areas and communities tied to universities. The findings point to a broader challenge: without stronger access to infrastructure, skills, and education, AI’s benefits risk remaining concentrated rather than broadly shared. Read the full blog here.
The maker of the large-language model Claude became the latest AI giant to file to go public.
Hundreds took to the streets in Kenya after the US announced plans to build an Ebola quarantine center on a Kenyan air base, with protesters warning the facility risks introducing a disease the country has never recorded. President Ruto is defending the project.